FACTORS ASSOCIATED WITH CA125 AND NT-proBNP IN ACUTE HEART FAILURE

Minh Châu Trương, Ngọc Hoa Châu

Main Article Content

Abstract

Background: Congestion is a primary symptom in patients with acute heart failure, but its clinical identification remains challenging. NT-proBNP is a standard biomarker for heart failure, reflecting vascular congestion rather than tissue congestion. This study investigates the relationship between clinical signs of congestion, right heart factors on echocardiography, and the biomarkers CA125 and NT-proBNP in patients with acute heart failure. Methods: This was a cross-sectional descriptive study involving 316 patients with acute heart failure. Symptoms of congestion, CA125, and NT-proBNP were assessed at the time of hospital admission. Echocardiography was performed during hospitalization. The relationship between clinical signs of congestion, right heart factors, and the biomarkers CA125 and NT-proBNP was evaluated using multiple regression coefficients (R²). Results: The average age of participants was 66.6 ± 14.8 years, with 164 (51.9%) being female. The majority of patients, 254 (80.4%), were admitted due to acute decompensated heart failure. The median (interquartile range) for NT-proBNP was 6.644 (3.973 – 12.360) pg/ml, and for CA125 it was 56 (27 – 140) U/mL. In the multivariate linear regression model, the most significant factor associated with changes in NT-proBNP was renal failure (R² = 0.1276, P < 0.001). NT-proBNP was found to be associated with the congestion index, but not with right heart factors. The most significant factor associated with changes in CA125 was the congestion index (R² = 0.0896, P < 0.001). CA125 was also associated with right heart factors, such as tricuspid regurgitation (R² = 0.0166, P = 0.025). Conclusions: In patients with acute heart failure, the most important factor associated with NT-proBNP is renal failure. For CA125, the key contributing factors are the congestion index and tricuspid regurgitation. These findings support the use of CA125 as a biomarker for congestion and right heart involvement in patients with acute heart failure

Article Details

References

Girerd N, Seronde MF, Coiro S, et al. Integrative Assessment of Congestion in Heart Failure Throughout the Patient Journey. JACC Heart failure. Apr 2018;6(4):273-285. doi:10.1016/j.jchf.2017.09.023
2. Núñez J, de la Espriella R, Miñana G, et al. Antigen carbohydrate 125 as a biomarker in heart failure: a narrative review. European journal of heart failure. Sep 2021;23(9):1445-1457. doi:10.1002/ejhf.2295
3. Sasamoto N, Vitonis AF, Fichorova RN, Yamamoto HS, Terry KL, Cramer DW. Racial/ethnic differences in average CA125 and CA15.3 values and its correlates among postmenopausal women in the USA. Cancer causes & control : CCC. Mar 2021;32(3):299-309. doi:10.1007/s10552-020-01384-z
4. Núñez J, Bayés-Genís A, Revuelta-López E, et al. Clinical Role of CA125 in Worsening Heart Failure: A BIOSTAT-CHF Study Subanalysis. JACC Heart failure. May 2020;8(5): 386-397. doi:10.1016/j.jchf.2019. 12.005
5. Miñana G, de la Espriella R, Mollar A, et al. Factors associated with plasma antigen carbohydrate 125 and amino-terminal pro-B-type natriuretic peptide concentrations in acute heart failure. European heart journal Acute cardiovascular care. Aug 2020;9(5):437-447. doi:10.1177/2048872620908033
6. McDonagh TA, Metra M, Adamo M, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. European heart journal. Sep 21 2021;42(36): 3599-3726. doi:10.1093/eurheartj/ehab368
7. Zoghbi WA, Adams D, Bonow RO, et al. Recommendations for Noninvasive Evaluation of Native Valvular Regurgitation: A Report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. Journal of the American Society of Echocardiography. 2017; 30(4): 303-371. doi:10.1016/j.echo.2017. 01.007
8. Llàcer P, Gallardo M, Palau P, et al. Comparison between CA125 and NT-proBNP for evaluating congestion in acute heart failure. Medicina clinica. Jun 25 2021;156(12):589-594. Comparación entre CA125 y NT-proBNP para valorar la congestión en insuficiencia cardíaca aguda. doi:10.1016/j.medcli.2020.05.063